RIO DE JANEIRO, BRAZIL - Brazil's National Health Regulatory Agency (ANVISA) announced this Monday, May 31, that it is analyzing a request to authorize the Pfizer/BioNTech coronavirus vaccine for children age 12 and older.
According to the agency, Pfizer's request to include this age group in the vaccine package insert was submitted on May 13 and ANVISA's deadline for evaluation is up to 30 days. Currently, the vaccine is permanently authorized in Brazil for people aged 16 and older. The country has received 3.4 million vaccine doses so far, out of a contracted total of 200 . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here